tiprankstipranks
Trending News
More News >

James Garner Insider Profile

4 Followers
James Garner, Chief Executive Officer at Kazia Therapeutics Ltd, holds 52.50M shares in Percheron Therapeutics (Ticker: PERCF), holds 781.82K shares in Kazia Therapeutics Ltd (Ticker: DE:NV9). Most recently, James Garner Bought ― shares of Percheron Therapeutics on Jul 01, 2025 for an estimated value of 25.00K.
tipranks
James  Garner

James Garner
Kazia Therapeutics Ltd (NV9)
Chief Executive Officer

Not Ranked
Ranked #58,248 out of 102,551 Corporate Insiders
James Garner has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$525K
100.00%
A breakdown of James Garner's holdings

Insider Roles

Percheron Therapeutics
(PERCF)
Chief Executive Officer
Roles that James Garner holds in companies

Most Profitable Insider Trade

Stock:
Percheron Therapeutics
(PERCF)
Rating:Informative Buy
Date:Nov 20, 2023 - Nov 20, 2024
Return:-16.00%
The most profitable trade made by James Garner

James Garner's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NV9
Kazia Therapeutics Ltd
Mar 06, 2023
Informative Buy
20.00K
Percheron Therapeutics
Jul 01, 2025
Chief Executive Officer
Informative Buy
25.00K
$525.00K
List of latest transactions for each holding click on a transaction to see James Garner's performance on stock

James Garner insider profile FAQ

What is the percentage of profitable transactions made by James Garner?
The percentage of profitable transactions made by James Garner is ―.
    What is the average return per transaction made by James Garner?
    The average return per transaction made by James Garner is ―.
      What stocks does James Garner hold?
      James Garner holds: DE:NV9, PERCF stocks.
        What was James Garner’s latest transaction?
        James Garner latest transaction was an Informative Buy of $25.00K.
          What was James Garner's most profitable transaction?
          James Garner’s most profitable transaction was an Informative Buy of PERCF stock on November 20, 2023. The return on the trade was -16.00%.
            What is James Garner's role in Kazia Therapeutics Ltd?
            James Garner's role in Kazia Therapeutics Ltd is Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.